Sirolimus addition to tacrolimus-based immunosuppression induces complete remission of post-transplant lymphoproliferative disorder in a liver transplant recipient.
Katharina
K
Staufer
Martina
M
Sterneck
Hansjoerg
H
Schaefer
Bjoern
B
Nashan
Lutz
L
Fischer
D001379:Azathioprine / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D016031:Liver Transplantation / Q000009:adverse effects*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy* / Q000209:etiology; D020123:Sirolimus / Q000008:administration & dosage*; D013256:Steroids / Q000627:therapeutic use; D016559:Tacrolimus / Q000008:administration & dosage*; D055815:Young Adult
D013256:Steroids; D001379:Azathioprine; D020123:Sirolimus; D016559:Tacrolimus